These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 10916956
21. [Uterine pathology in women with breast cancer treated with tamoxifen]. Carcangiu ML. Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417 [No Abstract] [Full Text] [Related]
22. Endometrial cancer and tamoxifen. Burke C. Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168 [No Abstract] [Full Text] [Related]
23. [Tamoxifen, endometrial cancer risk and liquid based cytology. A paradigmatic case]. Fambrini M, Buccoliero AM, Pieralli A, Andersson KL, Mattei A, Scarselli G, Taddei G, Marchionni M. Minerva Ginecol; 2011 Oct; 63(5):465-70. PubMed ID: 21926955 [Abstract] [Full Text] [Related]
24. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. J Natl Cancer Inst; 2005 Nov 16; 97(22):1652-62. PubMed ID: 16288118 [Abstract] [Full Text] [Related]
25. [Endometrial cancers arising in polyps associated with tamoxifen use]. Mbatsogo BA, Le Bouëdec G, Michy T, Bourdel N, Fouilloux G, Dauplat J. Gynecol Obstet Fertil; 2005 Dec 16; 33(12):975-9. PubMed ID: 16321556 [Abstract] [Full Text] [Related]
28. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen]. Kuzmanov B. Akush Ginekol (Sofiia); 2004 Dec 16; 43(3):32-3. PubMed ID: 15341254 [Abstract] [Full Text] [Related]
29. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data. Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Pollard S, Clack G, Cuzick J, Coibion M, Bianco AR. BJOG; 2003 Dec 16; 110(12):1099-106. PubMed ID: 14664881 [Abstract] [Full Text] [Related]
30. High-grade endometrial stromal sarcoma following tamoxifen treatment. Engin H. Gynecol Oncol; 2008 Jan 16; 108(1):253-4. PubMed ID: 17928038 [No Abstract] [Full Text] [Related]
31. [Cancer of the endometrium caused by antiestrogens]. Le Bouëdec G, Dauplat J. Rev Fr Gynecol Obstet; 1992 Jun 16; 87(6):345-8. PubMed ID: 1631476 [Abstract] [Full Text] [Related]
32. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A. J Clin Oncol; 2007 Feb 10; 25(5):486-92. PubMed ID: 17200148 [Abstract] [Full Text] [Related]
33. The nature of tamoxifen action in the control of female breast cancer. Kodama M, Kodama T. In Vivo; 2001 Feb 10; 15(4):319-25. PubMed ID: 11695224 [Abstract] [Full Text] [Related]
39. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Cohen I. Gynecol Oncol; 2004 Aug 10; 94(2):256-66. PubMed ID: 15297160 [Abstract] [Full Text] [Related]
40. Longitudinal hysteroscopic follow-up during tamoxifen treatment. Neven P, De Muylder X, Van Belle Y, Van Hooff I, Vanderick G. Lancet; 1998 Jan 03; 351(9095):36. PubMed ID: 9433432 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]